Antisense antiviral compounds and methods for treating a filovirus infection
    2.
    发明申请
    Antisense antiviral compounds and methods for treating a filovirus infection 有权
    反义抗病毒化合物和治疗病毒感染的方法

    公开(公告)号:US20060205693A1

    公开(公告)日:2006-09-14

    申请号:US11264444

    申请日:2005-10-31

    IPC分类号: A61K48/00

    摘要: The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Filoviridae family, and in the treatment of a viral infection. The compounds and methods relate to the treatment of viral infections in mammals including primates by Ebola and Marburg viruses. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides having: a) a nuclease resistant backbone, b) 15-40 nucleotide bases, and c) a targeting sequence of at least 15 bases in length that hybridizes to a target region selected from the following: i) the AUG start site region of VP35, as exemplified by antisense compounds SEQ ID NO:21-26, ii) the AUG start site region of VP24, as exemplified by antisense compound SEQ ID NO:34, iii) the region 85 to 65 base pairs upstream of the AUG start site of VP24, as exemplified by SEQ ID NO:39, iv) the AUG start site region of polymerase L, as exemplified by antisense compound SEQ ID NO: 17, and v) combinations of (i), (ii), (iii), and/or (iv).

    摘要翻译: 本发明提供了反义抗病毒化合物及其在抑制丝状病毒科病毒生长和用于病毒感染治疗中的用途和生产方法。 该化合物和方法涉及哺乳动物中的病毒感染的治疗,包括埃博拉和马尔堡病毒的灵长类动物。 反义抗病毒化合物是基本上不带电荷的吗啉代寡核苷酸,其具有:a)核酸酶抗性主链,b)15-40个核苷酸碱基,和c)长度为至少15个碱基的靶向序列与选自以下的靶区域杂交: i)VP35的AUG起始位点区域,如反义化合物SEQ ID NO:21-26所示,ii)VP24的AUG起始位点区域,如反义化合物SEQ ID NO:34所示,iii)区域85至 VP24的AUG起始位点上游65个碱基对,如SEQ ID NO:39所示,iv)聚合酶L的AUG起始位点区域,如反义化合物SEQ ID NO:17所示,v)(i ),(ii),(iii)和/或(iv)。

    Antisense antiviral compound and method for treating influenza viral infection
    3.
    发明申请
    Antisense antiviral compound and method for treating influenza viral infection 审中-公开
    反义抗病毒化合物及治疗流感病毒感染的方法

    公开(公告)号:US20070004661A1

    公开(公告)日:2007-01-04

    申请号:US11433213

    申请日:2006-05-11

    摘要: The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Orthomyxoviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of influenza virus infection in a mammal. The antisense antiviral compounds are substantially uncharged, including partially positively charged, morpholino oligonucleotides having 1) a nuclease resistant backbone, 2) 12-40 nucleotide bases, and 3) a targeting sequence of at least 12 bases in length that hybridizes to a target region selected from the following: a) the 5′ or 3′ terminal 25 bases of the negative sense viral RNA segment of Influenzavirus A, Influenzavirus B and Influenzavirus C; b) the terminal 25 bases of the 3′ terminus of the positive sense cRNA and; and c) the 50 bases surrounding the AUG start codon of an influenza viral mRNA.

    摘要翻译: 本发明提供反义抗病毒化合物及其在抑制正粘病毒科的病毒生长和用于病毒感染治疗中的用途和生产方法。 该化合物特别可用于治疗哺乳动物的流感病毒感染。 反义抗病毒化合物基本上不带电,包括部分带正电荷的吗啉代寡核苷酸,其具有1)核酸酶抗性主链,2)12-40个核苷酸碱基,和3)与目标区域杂交的至少12个碱基长度的靶向序列 选自以下:a)流感病毒A,流感病毒B和流感病毒C的阴性病毒RNA片段的5'或3'末端25个碱基; b)正义cRNA的3'末端的末端25个碱基; 和c)围绕流感病毒mRNA的AUG起始密码子的50个碱基。

    Antisense antiviral compound and method for treating influenza viral infection
    4.
    发明申请
    Antisense antiviral compound and method for treating influenza viral infection 有权
    反义抗病毒化合物及治疗流感病毒感染的方法

    公开(公告)号:US20060148747A1

    公开(公告)日:2006-07-06

    申请号:US11259434

    申请日:2005-10-25

    摘要: The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Orthomyxoviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of influenza virus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides having 1) a nuclease resistant backbone, 2) 12-40 nucleotide bases, and 3) a targeting sequence of at least 12 bases in length that hybridizes to a target region selected from the following: a) the 5′ or 3′ terminal 25 bases of the negative sense viral RNA segment of Influenzavirus A, Influenzavirus B and Influenzavirus C; b) the terminal 25 bases of the 3′ terminus of the positive sense cRNA and; and c) the 50 bases surrounding the AUG start codon of an influenza viral mRNA.

    摘要翻译: 本发明提供反义抗病毒化合物及其在抑制正粘病毒科的病毒生长和用于病毒感染治疗中的用途和生产方法。 该化合物特别可用于治疗哺乳动物的流感病毒感染。 反义抗病毒化合物是基本上不带电荷的吗啉代寡核苷酸,其具有1)核酸酶抗性主链,2)12-40个核苷酸碱基,和3)长度为至少12个碱基的靶向序列与选自以下的靶区域杂交: )流感病毒A,流感病毒B和流感病毒C的负义病毒RNA片段的5'或3'末端25个碱基; b)正义cRNA的3'末端的末端25个碱基; 和c)围绕流感病毒mRNA的AUG起始密码子的50个碱基。

    Antisense antiviral compound and method for treating arenavirus infection
    6.
    发明申请
    Antisense antiviral compound and method for treating arenavirus infection 有权
    反义抗病毒化合物及其治疗斑马疹病毒感染的方法

    公开(公告)号:US20070274957A1

    公开(公告)日:2007-11-29

    申请号:US11715572

    申请日:2007-03-07

    IPC分类号: A61K48/00

    摘要: The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Arenaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Arenavirus infection in a mammal. The antisense antiviral compounds are substantially uncharged morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 19 nucleotide region of the 5′-terminal regions of the viral RNA, viral complementary RNA and/or mRNA identified by SEQ ID NO:1.

    摘要翻译: 本发明提供了反义抗病毒化合物及其在抑制竞争链球菌科家族病毒生长和用于病毒感染治疗中的用途和生产方法。 这些化合物特别可用于治疗哺乳动物中的雷亚病毒感染。 反义抗病毒化合物是基本上不带电荷的吗啉代寡核苷酸具有12-40个亚基的序列,包括至少12个亚基,其具有与5'末端区域的19个核苷酸区域内的病毒RNA序列相关的区域互补的靶向序列 的病毒RNA,由SEQ ID NO:1鉴定的病毒互补RNA和/或mRNA。

    Antisense antiviral agent and method for treating ssRNA viral infection
    8.
    发明申请
    Antisense antiviral agent and method for treating ssRNA viral infection 失效
    反义抗病毒药物和治疗ssRNA病毒感染的方法

    公开(公告)号:US20070265214A1

    公开(公告)日:2007-11-15

    申请号:US11431968

    申请日:2006-05-10

    IPC分类号: A61K31/675

    CPC分类号: A61K31/675

    摘要: The invention provides antisense antiviral compounds and methods of their use in inhibition of growth of viruses of the picornavirus, calicivirus, togavirus and flavivirus families, as in treatment of a viral infection. The antisense antiviral compounds have morpholino subunits linked by uncharged phosphorodiamidate linkages interspersed with cationic phosphorodiamidate linkages.

    摘要翻译: 本发明提供反义抗病毒化合物及其用于抑制微小核糖核酸病毒,杯状病毒,披膜病毒和黄病毒家族病毒生长的方法,如治疗病毒感染。 反义抗病毒化合物具有通过分散有阳离子磷酰二胺键的不带电的磷酰二胺键连接的吗啉亚基。

    Antisense antiviral compound and method for treating picornavirus infection
    9.
    发明申请
    Antisense antiviral compound and method for treating picornavirus infection 失效
    反义抗病毒化合物及治疗小RNA病毒感染的方法

    公开(公告)号:US20070129323A1

    公开(公告)日:2007-06-07

    申请号:US11518058

    申请日:2006-09-08

    摘要: The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Picornaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Enterovirus and/or Rhinovirus infection in a mammal. The antisense antiviral compounds are substantially uncharged, including partially positively charged, morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 32 nucleotide region of the viral 5′ untranslated region identified by SEQ ID NO:4.

    摘要翻译: 本发明提供反义抗病毒化合物及其在抑制小核糖核酸病毒科家族病毒生长和用于病毒感染治疗中的用途和生产方法。 所述化合物特别可用于治疗哺乳动物中的肠病毒和/或鼻病毒感染。 反义抗病毒化合物是基本上不带电的,包括部分带正电荷的吗啉代寡核苷酸具有12-40个亚基的序列,包括至少12个亚基,其具有与与32个核苷酸区域内的病毒RNA序列相关的区域互补的靶向序列 由SEQ ID NO:4鉴定的病毒5'非翻译区。

    Antisense antiviral compound and method for treating picornavirus infection
    10.
    发明申请
    Antisense antiviral compound and method for treating picornavirus infection 失效
    反义抗病毒化合物及治疗小RNA病毒感染的方法

    公开(公告)号:US20070066556A1

    公开(公告)日:2007-03-22

    申请号:US11517757

    申请日:2006-09-08

    IPC分类号: A61K48/00 C07F9/6533

    摘要: The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Picornaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Enterovirus and/or Rhinovirus infection in a mammal. The antisense antiviral compounds are substantially uncharged, morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 32 nucleotide region of the viral 5′ untranslated region identified by SEQ ID NO:7.

    摘要翻译: 本发明提供反义抗病毒化合物及其在抑制小核糖核酸病毒科家族病毒生长和用于病毒感染治疗中的用途和生产方法。 所述化合物特别可用于治疗哺乳动物中的肠病毒和/或鼻病毒感染。 反义抗病毒化合物基本上不带电,吗啉代寡核苷酸具有12-40个亚基的序列,包括至少12个亚基,其具有与病毒5'非翻译的32个核苷酸区域内的病毒RNA序列相关的区域互补的靶向序列 由SEQ ID NO:7鉴定的区域。